In recent years, the intracellular oxidation-reduction (redox) state has gained increasing attention as a critical mediator of cell signaling, gene expression changes and proliferation. This review discusses the evidence for a redox cycle (i.e., fluctuation in the cellular redox state) regulating the cell cycle. The presence of redox-sensitive motifs (cysteine residues, metal co-factors in kinases and phosphatases) in several cell cycle regulatory proteins indicate periodic oscillations in intracellular redox state could play a central role in regulating progression from G 0 /G 1 to S to G 2 and M cell cycle phases. Fluctuations in the intracellular redox state during cell cycle progression could represent a fundamental mechanism linking oxidative metabolic processes to cell cycle regulatory processes. Proliferative disorders are central to a variety of human pathophysiological conditions thought to involve oxidative stress. Therefore, a more complete understanding of redox control of the cell cycle could provide a biochemical rationale for manipulating aberrant cell proliferation.
Introduction
Cellular proliferation encompasses tightly regulated biochemical and genetic pathways, the loss of which can lead to aberrant proliferation. In recent years, the role of the intracellular redox state as a growth regulator is increasingly becoming appreciated . Cellular redox state is a delicate balance between the levels of reactive oxygen species (ROS) produced during metabolism and the antioxidant system that scavenges them. In general, ROS contain one or more unpaired electrons in their highest occupied orbital. The partial reduction of molecular oxygen results in the production of superoxide (O 2 À ) and hydrogen peroxide (H 2 O 2 ) (Halliwell and Gutteridge, 1999) . O 2 À and H 2 O 2 react with transition metal ions (e.g. cuprous and ferrous ions) through Fenton and Haber-Weiss chemistry, promoting further radical generation, including the highly reactive hydroxyl radical ( OH) (Halliwell and Gutteridge, 1992) . Cells can generate ROS from exogenous sources as well as endogenously. Endogenously, ROS are largely produced as oxidative by-products of cellular metabolism; mitochondria, accounting for approximately 1-2% of molecular oxygen consumed, are the major site of O 2 À production. Other endogenous sources of ROS include the superoxide-generating nicotinamide adenine dinucleotide phosphate (reduced form) (NADPH) oxidase complex, peroxisomes that generate H 2 O 2 , metabolism of fatty acid chains, cytochrome P450 reductase, xanthine oxidase, myeloperoxidase and nitric oxide synthase (Massey et al., 1969; Bredt et al., 1991; Bokoch and Knaus, 2003; Schrader and Fahimi, 2004; Zangar et al., 2004; Klebanoff, 2005) . Additionally, recent evidence suggests interaction between specific receptorligands generates H 2 O 2 (DeYulia et al., 2005) . ROS, diverse and abundant in biological systems, were traditionally thought of as toxic products leading to damage of cellular components, including nucleic acids, proteins and lipids resulting in cell death (apoptosis and necrosis). However, recent evidence suggests ROS could be beneficial and function as signaling molecules regulating proliferation and growth arrest (Rhee, 1999) . This dual function of ROS (signaling molecules and toxins) could be due to the differences in their concentrations, pulse duration and sub-cellular localization. Such a threshold concept of ROS regulating multiple biological processes is evident from a recent report of H 2 O 2 regulating both proliferation and cell death (Laurent et al., 2005) . NIH3T3 fibroblasts treated with 0.02-0.13 mM H 2 O 2 enhanced proliferation, whereas treatment with 0.25-2 mM H 2 O 2 or compounds (buthionine-(S, R)-sulfoximine (BSO), superoxide dismutases (SOD) mimics) known to increase intracellular H 2 O 2 levels resulted in growth arrest and cell death. Therefore, while higher levels of ROS could be toxic, low levels of ROS are necessary for proper functioning of cellular processes including proliferation.
Cells protect themselves against the reactive and damaging effects of ROS by expressing antioxidant enzymes like SOD, catalase (CAT), glutathione peroxidase (GPx) and other small molecular ROS scavengers. Of the enzymatic antioxidants, SOD converts O 2 À into H 2 O 2 (McCord and Fridovich, 1969) . There are three forms of SOD: CuZnSOD (SOD1), the cytoplasmic and nuclear form; MnSOD (SOD2), the mitochondrial form (Fridovich, 1989) ; and extracellular SOD (EcSOD, SOD3), found in the plasma membrane (Folz and Crapo, 1994) . CAT specifically reduces H 2 O 2 , whereas GPx reduces both H 2 O 2 and organic hydroperoxides, utilizing reduced glutathione (GSH) as an electron donor. While CAT is localized primarily in the peroxisomes and cytoplasm, different isozymes of GPx are found in most sub-cellular compartments (Yamamoto et al., 1988; Oberley et al., 1990) . Other cellular peroxidase scavenging enzyme systems include thioredoxin, glutaredoxins and the six-member family of peroxiredoxins Tanaka et al., 2000; Fernandes and Holmgren, 2004) . Cysteine, GSH, vitamins C and E (ascorbic acid and a-tocopherol), among others, constitute a pool of small molecular weight non-enzymatic antioxidants (Di Mascio et al., 1991) . GSH is ubiquitously found within the cell in both reduced (GSH) and oxidized (GSSG) forms (Schafer and Buettner, 2001) . GSSG can be reduced back to GSH by glutathione reductase, at the cost of NADPH, and also by the thioredoxin or glutaredoxin systems. For this reason, changes in the GSH/GSSG ratio are routinely used as indicators of perturbation in the intracellular redox state.
Intracellular redox state and cell cycle progression At the heart of every organism's development and growth process is its ability to divide. In normal cells, growth and division is a highly ordered, regulated series of events. When signaled by various mitogenic stimuli (growth factors), cells give rise to two daughter cells by transiting through the different cell cycle phases (G 0 to G 1 to S to G 2 to M). In the S phase, the cellular DNA is duplicated, in the following gap phase (G 2 ), cells prepare for mitosis and, upon entering the M phase, the DNA gets segregated and the cell divides into two. G 1 , however, is the critical phase of the cycle; it determines if cells continue in the cycle or if proliferation is arrested. Temin (1971) first proposed the presence of a G 1 -phase decision point, after which cells became independent of mitogenic signaling. Later, Pardee (1974) named this point the 'restriction point' and defined it as the point after which a cell is committed to enter the S phase, more or less independent of external conditions.
The first evidence of a redox cycle within the cell cycle came in 1931 from Rapkine (1931) , who demonstrated the presence of soluble thiols that fluctuated cyclically. Using sea urchin eggs, he observed levels of soluble thiols decreased until metaphase and then increased toward mitosis. Later, in 1960, Kawamura et al. also used sea urchin eggs to show increased protein thiol (-SH) staining in prophase as the mitotic spindle was assembling. This SH staining remained high as cells moved into metaphase, gradually decreased in anaphase and was almost undetectable in telophase (Kawamura, 1960) . Using synchronous HeLa cells, Mauro et al. (1969) further dissected the changes occurring in protein-bound and non-protein sulfhydryl (-SH) and disulfide (-SS-) groups in each phase of the cell cycle. The authors in this study observed the concentration of non-protein -SH dropped 10-fold from early G 1 to late G 1 and then rose almost 30-fold by the end of S phase. In contrast, the protein-bound -SH groups rose during G 1 and dropped during the S phase (Mauro et al., 1969) .
The concept of a redox cycle regulating the cell cycle is further supported by a recent report from Tu et al. (2005) . Budding yeast exhibit a metabolic redox cycle consisting of a reductive non-respiratory phase and an oxidative respiratory phase. This metabolic redox cycle coordinates with periods of gene expression regulating essential cellular and metabolic events (Tu et al., 2005) . Many of the genes regulating DNA replication and cell cycle progression are expressed during its reductive phase with cell cycle initiation occurring very late during the oxidative phase. Consistent with these results, we have shown previously that a transient increase in prooxidant levels early in G 1 is required for the cells to transit from G 1 into the S phase (Menon et al., 2003) . Inhibiting this pro-oxidant event using an antioxidant like N-acetyl L-cysteine (NAC) arrests the cells in the G 1 phase. Additionally, we found the fluorescence of a pro-oxidant sensitive dye was maximal in late S and G 2 þ M phases of the HeLa cell cycle compared to G 1 (Goswami et al., 2000) . Additional reports from other laboratories have shown sub-lethal doses of ROS (O 2 À and H 2 O 2 ) added exogenously stimulated proliferation in cultured hamster fibroblasts (Burdon et al., , 1990 Stirpe et al., 1991; Burdon and Gill, 1993) . Interestingly, the effect of metabolic redox reactions on growth was not exclusive to mammalian cells, but can also be seen in Dictyostelium discoideum, one of the simplest organisms capable of forming multicellular structures. When conditions are favorable, D. discoideum survive as individual amoeba, but in response to starvation, the individual cells form sporecontaining aggregates. During this process, O 2 À generation is required for transition to a multicellular developmental phase. Furthermore, scavenging O 2 À can prevent the formation of multicellular aggregates (Bloomfield and Pears, 2003) . Thus, the use of O 2 À as a signaling messenger by a lower eucaryote suggests this mode of signaling arose quite early during the evolutionary process and has been indispensable to every organism's growth and development.
The hypothesis of a redox cycle regulating the cell cycle is also supported by reports of antioxidant enzymes influencing cellular growth stage. MnSOD enzyme activity in NIH3T3 cells decreased during the S phase compared to G 0 . Cells possessing the ability of contact inhibition show higher SOD levels when proliferation halts; those not demonstrating densitydependent growth inhibition do not exhibit increased SOD levels (Oberley et al., 1995; Li and Oberley, 1998) . Earlier, we have shown quiescent (G 0 ) normal human fibroblasts cultured for a prolonged period of time lose the capacity to replicate DNA after sub-culture (Sarsour et al., 2005) . However, G 0 cells overexpressing MnSOD maintained their proliferative capacity, even after prolonged culture (Sarsour et al., 2005) . MnSOD overexpression inhibited the age-associated increase in p16 (cyclin-dependent kinase inhibitor (CKI)) protein levels (Sarsour et al., 2005) . It is believed this p16 inhibition protects the fibroblasts capacity to replicate DNA and divide (Sarsour et al., 2005) . These results support the idea that O 2 À is required for signal transduction in actively proliferating cells, whereas growth inhibition requires a reduction in mitogenic signaling, possibly by decreasing O 2 À levels and increasing SOD activity. These observations not only underscore the importance of O 2 À signaling but also highlight the importance of SOD regulation during growth. Furthermore, because mitochondria are the major source of cellular ROS (O 2 À ), and SOD dismutases O 2 À , these results also support the hypothesis that mitochondrial oxidants could function as signaling molecules regulating cell cycle progression (Figure 1) .
Modulation of other antioxidant enzymes has also been shown to affect proliferation rates. Catalase overexpression in vascular smooth muscle cells inhibits proliferation and increases the apoptotic rate, indicating H 2 O 2 not only regulates proliferation but also survival (Brown et al., 1999) . We have shown overexpression of GPx4 (PhGPx) inhibits progression from G 1 to S, suggesting the possible involvement of lipid peroxidation-mediated signaling in cell cycle progression . In addition to antioxidant enzymes, cellular thiols also function as redox buffers and help maintain cellular redox potential. The major contributors to total thiol pools within the cell include the GSH/GSSG, thioredoxin/thioredoxin reductase and the cysteine/ cystine couples, among others (Schafer and Buettner, 2001; Jones et al., 2004) . Recent observations by Conour et al. (2004) indicate GSH content was significantly higher in the G 2 þ M phase compared to G 1 , suggesting cells in the G 2 þ M phase are at a more reduced state compared to the G 1 phase. S-phase cells showed an intermediate redox state (Conour et al., 2004) . Our laboratory, as well as others, has shown modulating intracellular redox state using NAC inhibits proliferation in mouse embryonic fibroblasts, hepatic stellate cells and vascular smooth muscle cells (Kim et al., 2001; Menon et al., 2003; Kyaw et al., 2004) . These results further support the hypothesis that intracellular redox state is a critical regulator of cell cycle progression.
It has also been observed that altering extracellular redox environment changes proliferation rates. DNA synthesis, measured by the incorporation of 5-bromo-2-deoxyuridine, was at its minimum when extracellular redox was kept in an oxidizing state. In contrast, DNA synthesis significantly increased as the reduction potential (E h ) shifted to a more reducing state (Jonas et al., 2002) . Hutter et al. (1997) measured changes in redox potential as cells progressed from an actively dividing to a contact inhibited growth state. The authors observed that actively dividing normal fibroblasts showed a reduction potential of À222 mV, this gradually increased and contact inhibited cell displayed a redox potential of À188 mV. Furthermore, to prove redox state fluctuations are the cause rather than the effect of proliferation, they used BSO (an inhibitor of g-glutamylcysteine synthase) to inhibit GSH synthesis. Treating cells with BSO resulted in a less reduced state and decreased proliferation. Conversely, it has been shown that fibroblasts cultured sparsely in the presence of ROS scavengers show reduced protein tyrosine phosphorylation after epidermal growth factor (EGF) stimulation, mimicking the behavior of contact inhibited fibroblasts (Pani et al., 2000) . Limoli et al. (2004) showed higher ROS levels in neuronal precursor cells when grown at low density compared to those grown at high density. Higher ROS levels were also associated with increased proliferation rates and metabolic activity, which could be inhibited with the antioxidant, a-lipoic acid (Limoli et al., 2004) . These reports further support the concept Figure 1 A schematic illustration of the redox control of cell cycle progression. There is an increase in the pro-oxidant state owing to ROS generation through cellular metabolism, growth factor stimulated receptor-ligand interaction and other exogenous sources. The transient change in ROS could modify the redox state (critical cysteine residues) of cell cycle regulatory proteins whose activity determines progression or arrest in proliferation. Antioxidant system can scavenge ROS and alter the redox environment and reverse the process.
that ROS could act like a dual-edged sword. Although proliferation occurs within a range of ROS levels, concentrations below or above this range result in growth arrest or cell death. The above results also suggest both the intra-(primarily mitochondria derived) and extracellular (receptor-ligand interaction) redox environments regulate cellular proliferation (Figure 1 ).
Intracellular redox state and cell cycle proteins
The influence of the cellular redox state on cell cycle regulatory proteins is not clearly understood. The tightly regulated progression through the cell cycle is brought about by periodic activation of cyclin and cyclindependent kinases (CDKs). The independent discoveries of cyclins in sea urchin oocytes, along with the simultaneous identification of maturation-promoting factors in frog oocytes and of CDC proteins in Saccharomyces cerevisiae, converged to give rise to the present-day concepts of cyclin-CDK complexes (Hartwell et al., 1970; Masui and Markert, 1971; Evans et al., 1983) . The seminal discovery of cyclin/CDK complexes is believed to be at the core of understanding cellular proliferation controls. Cell cycle progression requires precise signal integration arising from mitogenic activation of transduction cascades. This is then followed by efficient transcription, activity of cell cycle phase-specific regulatory proteins and timely rapid degradation of critical cell cycle regulators. Thus, the redox control of cell cycle progression can act on any, or all, of the stages in this molecular network.
The generation of ligand-stimulated ROS plays an important role in mitogenic and growth factor signaling required for cellular progression through the cell cycle. Administering ROS activates a wide variety of proteins in various pathways; for example, platelet-derived growth factor (PDGF), EGF, mitogen-activated protein kinase (MAPK), protein kinase C (PKC) and protein kinase B (PKB/Akt) signal-transduction pathways. H 2 O 2 generation during the activation of PDGF, transforming growth factor and EGF receptor signaling has also been well established (Sundaresan et al., 1995; Bae et al., 1997; Brar et al., 1999; Junn et al., 2000; Okuyama et al., 2001) . The H 2 O 2 generated results in tyrosine phosphorylation of the receptor, which subsequently activates MAPK (Gamou and Shimizu, 1995) . The H 2 O 2 -dependent activation of the MAPK pathway can also activate antioxidant enzymes or other detoxifying genes like GCLC (glutamate-cysteine ligase, catalytic subunit) via the antioxidant response elements found in the promoter regions of these enzymes . PKC enzyme activity can also be increased by exposure to O 2 À , inducing disulfide bond formation and release of zinc from the cysteine-rich region of the enzyme (Knapp and Klann, 2000) . In addition to the redox state altering kinase activity, regulation of protein tyrosine phosphatases and low molecular weight phosphotyrosine phosphatases by ROS has been extensively studied (Chiarugi et al., 2003) . Recently, a bioinformatic approach to identify the redox-sensitive cell cycle proteins revealed almost 92 candidate proteins that could influence cellular progression in a redox-sensitive manner, of which only 24% have been identified experimentally (Conour et al., 2004) . Of note, about 20% of the 92 proteins function in the G 1 phase, only 10% in the S phase, but as much as 50% of the major redox motif-containing proteins were present in the G 2 þ M phase (Conour et al., 2004) .
Redox regulation of G 1 and S cell cycle regulatory proteins Cyclin D/CDK4/6. Following mitogenic stimulation, the first cyclins to be activated in G 1 are the D-type cyclins (D1, D2 and D3) that associate with its CDK partner, CDK4 or CDK6 (Sherr, 1995) . H 2 O 2 exposures activate cyclin D1 accumulation in Her14 fibroblasts by inhibiting cyclin D1 protein degradation (Martinez Munoz et al., 2001 ). Degradation of cyclins by the ubiquitin-proteasome pathway is a key step in the regulation of cell cycle progression. The role of redox environment in regulating this pathway has also been reported. The activities of ubiquitin-activating enzyme (E1) and ubiquitin-conjugating enzyme (E2) were both inhibited with increased GSSG:GSH ratios (JahngenHodge et al., 1997). In addition, it was shown that reversible S-thiolation of E1 and E2 enzymes regulates the ubiquitin-dependent proteolysis in response to altered redox environment (Obin et al., 1998) . Furthermore, the 20S proteasome activity in S. cerevisiae was also reported to be inhibited by S-glutathionylation following H 2 O 2 treatment (Demasi et al., 2003) . These observations suggest redox regulation of the proteasome degradation machinery could regulate cyclin D1 levels.
Alternatively, redox modification of cyclin D1 itself could regulate its protein levels. Cyclin D1 contains two phosphorylation sites, on residues Thr286 and Thr288, which regulate its degradation. During late G 1 , cyclin D1 is proteasomally degraded following its phosphorylation at Thr286 by glycogen synthase kinase (GSK-3b) (Diehl et al., 1998) . Degradation can also be mediated independent of GSK-3b via phosphorylation at the Thr288 residue by Mirk/dyrk kinase (Zou et al., 2004) . We propose that redox regulation of cyclin D1 can occur through changes in redox state of critical cysteines, most likely the cysteine residue at position 285. Redox modification at cysteine 285 (-SH reduced to -S-S-oxidized state, or vice versa) could result in conformational change, which could then affect phosphorylation at Thr286 and/or -288 affecting its degradation. As cyclins are positive regulators of the cyclin/ CDK kinase activities, redox modifications of cyclin D1 protein levels would be expected to significantly affect cyclin D1/CDK4/6 kinase activities.
A resultant effect from post-translational modification in one amino acid affecting the post-translational modification in a neighboring amino acid was originally suggested for the 'binary switches' concept for the histone code hypothesis (Fischle et al., 2003) . Histone modifications are both highly reversible (e.g. lysine acetylation and serine/threonine phosphorylation) and stable (e.g. lysine and arginine methylation). Thus, methyl/phos and acetyl/phos switching mechanisms have been suggested to play a key role in controlling the genomes' capacity to inherit, store and release biological information. Likewise, a redox-dependent phosphorylation (redox-phos switch) has been shown to regulate protein kinase A and protein kinase B (AKT) activities (Murata et al., 2003; Humphries et al., 2005) . The C-subunit of protein kinase A contains two cysteine residues (Cys199 and Cys343) located close to two major phosphorylation sites (Thr197 and Ser338). Thiol-redox modification of Cys199 and Cys343 results in disulfide bond formation that enhances Thr197 and Ser338 dephosphorylation. These redox modifications of protein kinase A phosphorylation decreased its activity (Humphries et al., 2005) . Likewise, oxidative stressinduced disulfide bond formation between Cys297 and Cys311 decreased AKT kinase activity by activating protein phosphatase 2A-dependent dephosphorylation of Thr308 and Ser473 (Murata et al., 2003) . It will be of interest to determine if a redox-phos switch regulates cyclin D1 protein levels.
A redox-dependent transcriptional response of cyclin D1 gene expression to mitogenic signaling has also been reported in cells re-entering the cell cycle from the G 0 phase (Burch and Heintz, 2005) . The promoter region of cyclin D1 gene contains binding sites for redox-sensitive transcription factors including cyclic adenosine monophosphate response element-binding protein, nuclear factor-kB (NF-kB), activator protein 1 and Sp1. Several reports show redox modifications of critical cysteines in these transcription factors regulate their DNA-binding activities (Abate et al., 1990; Toledano and Leonard, 1991; Manome et al., 1993; Ohba et al., 1994; Janssen et al., 1995; Lo and Cruz, 1995) . Hence, redox-state-dependent modulation of the activity of these transcription factors could significantly influence cyclin D1 transcription.
Earlier work of Rainwater et al. (1995) shows that cysteine redox modifications regulate p53 DNA-binding activity. The tumor suppressor protein p53 is a transcription factor regulating transcription of numerous genes following genotoxic insult and is frequently mutated in many cancer types. The DNA-binding domain of p53 contains four conserved cysteine residues (135, 141, 275 and 277); site-directed mutagenesis of residues 275 and 277 demonstrates these cysteines play a role in redox regulation of p53 binding to DNA in vitro (Rainwater et al., 1995) . Downstream targets of p53 are numerous and include p21, GPx and many other redox enzymes involved in multiple cellular processes (Di Leonardo et al., 1994; Polyak et al., 1997; Tan et al., 1999) . Adenosine diphosphate ribosylation factor (ARF), another tumor-suppressing protein encoded by the inhibitors of CDK4 (INK4)/ARF locus, inhibits Mdm2-mediated p53 degradation. In the presence of oxidizing agents like H 2 O 2 , ARF reversibly forms oligomers involving three critical cysteine residues (Menendez et al., 2003) . These reports suggest that fluctuations in cellular redox environment could regulate the activity of multiple proteins that are known to control numerous biological processes including proliferation.
As cells transit through G 1 , cyclin E is the next cyclin to be synthesized. Cyclin E kinase activity, in association with CDK2, peaks in late G 1 . Once cells enter the S phase, cyclin E is degraded and CDK2 then associates with cyclin A. It is currently unknown if fluctuations in intracellular redox state influence cyclin E protein levels and activity.
Retinoblastoma and E2F. Once assembled and activated, cyclin D-CDK4/6 kinase can phosphorylate the retinoblastoma (Rb) protein (Pan et al., 2001) . Expression and phosphorylation of the Rb protein is redox regulated in human natural killer cells and fibroblasts treated with thiol antioxidants (Yamauchi and Bloom, 1997; Menon et al., 2003) . Rb phosphorylation releases the transcription factor E2F (Nevins, 1992) , which subsequently upregulates E2F-responsive genes required to enter the S phase. As discussed earlier, entry into the S phase is preceded by a transient increase in prooxidant levels (Menon et al., 2003) , which is consistent with a decrease in MnSOD activity in the S phase (Li and Oberley, 1998) . However, persistent increase in E2F is deleterious and induces apoptosis in serumstarved NIH3T3 fibroblasts (Tanaka et al., 2002) . E2F overexpression-induced apoptosis is associated with increased ROS levels and inactivation of MnSOD transcription. E2F competes with the p50 subunit of NF-kB resulting in NF-kB inactivation. Inactivation of NF-kB decreased MnSOD transcription, which could then result in increased ROS levels (Tanaka et al., 2002) . These results further support the threshold concept of ROS function; lower levels of ROS are growth stimulatory, whereas higher levels of ROS are detrimental. Furthermore, these results also suggest that a feedback mechanism could link cell cycle regulatory proteins and antioxidant enzymes activity, thereby maintaining an appropriate redox environment conducive for proliferation. Additionally, MnSOD being a mitochondrial ROS-detoxifying enzyme, these results also suggest regulated levels of mitochondrial oxidants could influence cell cycle regulatory protein levels and activity, which subsequently regulates progression from one cell cycle phase to the next (Figure 1 ).
Redox regulation of mitotic cyclins. Once in the G 2 phase of the cycle, cyclin A binds and forms an active kinase complex with CDK1 that help cells to transit into mitosis. Progression through the M phase requires the activity of another phase-specific complex, cyclin B-CDK1 (Pines and Hunter, 1989) . A recent report shows CDK1 phosphorylates peroxiredoxin I inhibiting its oxidase activity. It is hypothesized that transient inhibition in peroxiredoxin I oxidase activity by mitotic cyclin/CDK phosphorylation would accumulate H 2 O 2 , which then stimulates progression from G 2 to M (Chang et al., 2002) . Another protein critical to G 2 checkpoint control and DNA repair is topoisomerase IIa (Topo IIa). We have shown previously the expression of Topo IIa is cell cycle regulated, primarily via changes in its mRNA stability (Goswami et al., 1996) . Topo IIa mRNA stability is regulated by redoxdependent protein binding to specific mRNA sequence in its 3 0 -untranslated region. Furthermore, our results also show increased fluorescence of a pro-oxidant dye in the G 2 and M phases of the HeLa cell cycle, indicative of an increased oxidation state and correlative with enhanced accumulation of Topo IIa mRNA levels. In contrast, the decreased oxidation state in G 1 correlates with decrease in Topo IIa mRNA levels (Goswami et al., 2000) . These results further support the hypothesis that periodic oscillations in ROS levels owing to changes in cellular metabolic redox reactions (redox cycle) could regulate the protein and activity of cyclin/CDKs, which in turn regulates progression from G 0 /G 1 to S to G 2 and M phases (Figure 1 ).
Redox regulation of CKIs. Whereas cyclin-CDK kinase complex activities act as positive regulators of the cell cycle, there is also a negative regulation in the form of CKIs, essentially functioning as the brakes during cellular transit (Grana and Reddy, 1995) . CKIs play a critical role in regulating the assembly and activity of the cyclin-CDK kinase complexes and are broadly classified into two families: INK4 and Cip/Kip (CDK inhibitory protein)/(kinase inhibitory protein). The INK4 family, consisting of four members (p16 (INK4A), p15 (INK4B), p18 (INK4C) and p19 (INK4D)), specifically binds and inhibits CDK4/6. Alternatively, the Cip/Kip family (p21cip, p27kip1 and p57kip2) has a broader specificity in inhibiting CDK activity. Although, comparatively, little is known about the redox regulation of most of the CKIs, several studies have established the effect of various redox manipulations on p21 protein expression. p21 protein is induced in response to the antioxidant epigallocatechin gallate; it binds and inhibits cyclin D1, thereby inhibiting proliferation of MCF10A cells (Liberto and Cobrinik, 2000) . p21 and p16 are involved in mediating NAC-induced G 1 arrest, which is p53 independent (Liu et al., 1999) . p21 is also regulated in a p53-independent manner by a posttranscriptional mechanism in cells exposed to diethymaleate, which depletes cellular GSH (Esposito et al., 1997) . We have shown previously that overexpression of MnSOD altered p21 and p16 protein levels in normal human skin fibroblasts (Sarsour et al., 2005) . These results suggest that p21 levels are sensitive to both antioxidants and pro-oxidants, indicating a prooxidant-antioxidant balance is required for the maintenance of appropriate levels of p21 during the cell cycle. Although the mechanisms regulating redox control of CKIs are unknown, it is speculated that redox-sensitive protein binding to the 3 0 -untranslated region mRNA could influence CKIs mRNA turnover and/or translation. We have previously proposed such a mechanism for cell cycle phase-dependent and redox regulation of Topo IIa expression, a G 2 checkpoint protein (Goswami et al., 2000) .
Redox regulation of Cdc25 phosphatase. Cdc25 is a family of dual-specific phosphatases that dephosphorylate pThr14 and pTyr15 on CDK and activate cyclin-CDK complex kinase activity (Sebastian et al., 1993) . Dunphy and Kumagai (1991) showed in vitro that phosphatase activity of cdc25 protein can be inhibited using Nethylmaleimide (thiol-alkylating agent) or mutating a single conserved cysteine residue. Recently, Savitsky and Finkel (2002) reported redox modification of Cdc25c protein in HeLa cells exposed to H 2 O 2 . H 2 O 2 caused the formation of an intramolecular disulfide bond between two critical site cysteines (Cys377 and Cys330) on the protein that resulted in its enhanced binding to 14-3-3 and subsequent degradation. Cdc25c harboring double mutants of Cys377 and Cys330 were resistant to H 2 O 2 -induced degradation (Savitsky and Finkel, 2002) . The consequence of these mutations on redox-sensitive progression during the cell cycle will require additional studies. However, these results do support the hypothesis that a feedback mechanism links metabolic redox reactions (ROS signaling) to the redox-sensitive cell cycle proteins, regulating normal cell cycle progression (Figure 1) .
Summary
In conclusion, compelling evidence from numerous observations supports our hypothesis that periodic oscillations in metabolic redox reactions (a redox cycle) represents a fundamental mechanism linking oxidative metabolic processes to cell cycle regulatory processes (Figure 1) . The presence of redox-sensitive motifs (cysteine residues, metal co-factors in kinases and phosphatases) in several cell cycle-regulatory proteins indicate fluctuations in intracellular redox state could play a central role in regulating progression through the cell cycle. The periodicity in intracellular redox state can be regulated by a delicate balance between production of ROS (cellular metabolism) and subsequent removal by antioxidants (both non-enzymatic and enzymatic pathways). Therefore, defects in ROS production and their removal could perturb the redox cycle, which in turn could lead to aberrant proliferation. Proliferative disorders are central to a variety of human pathophysiological conditions, for example, cancer, neurodegenerative disorders, atherosclerosis, aging, hyperplasia-induced fibrotic responses and wound healing. Interestingly, many of these proliferative disorders are also associated with defects in the antioxidant pathways, presumably affecting redox regulation of cellular proliferation. In fact, our earlier results demonstrate a differential redox response between non-malignant and malignant cells exposed to NAC. Although NAC exposure induced G 1 delay in non-malignant human breast epithelial cells, the same treatment did not perturb cell cycle progression in malignant breast epithelial cells (Menon et al., 2005) . Modulation of the redox state with NAC is also known to induce apoptosis selectively in transformed and tumor-derived cells compared to normal cells (Havre et al., 2002) . These results strongly support the hypothesis that loss of a redox control of the cell cycle could lead to aberrant proliferation. Therefore, it is hypothesized that reestablishing the redox cycle by manipulating the antioxidant pathways could reverse many aspects of aberrant cellular proliferation.
